JIR
GH icon

James Investment Research’s Guardant Health GH Stock Holding History

James Investment Research’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-380
Closed -$47K – 512
2021
Q2 		$47K Buy
+380
New +$51.1K ﹤0.01% 382
2021
Q1 		– Sell
-1,292
Closed -$167K – 511
2020
Q4 		$167K Buy
+1,292
New +$149K 0.02% 280
2020
Q2 		– Sell
-1,915
Closed -$133K – 468
2020
Q1 		$133K Hold
1,915
– – 0.01% 252
2019
Q4 		$150K Buy
+1,915
New +$138K 0.01% 302

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

James Investment Research's GH Position: Q3 2021 in Review

James Investment Research sold out of Guardant Health (GH) in Q3 2021, closing a stake of 380 shares — an estimated $47K sold.

James Investment Research first reported a position in GH in Q4 2019 and held it in 4 quarters. The position peaked at $167K in Q4 2020. 374 funds tracked by Wall St. Rank hold GH as of Q3 2021.

  • James Investment Research reported no remaining Guardant Health position as of Q3 2021 after selling out during the quarter.
  • James Investment Research sold 380 Guardant Health shares in Q3 2021, an estimated $47K.
  • James Investment Research first reported a position in Guardant Health in Q4 2019 and held it in 4 quarters.
  • James Investment Research's Guardant Health position peaked at $167K in Q4 2020.
  • 374 funds tracked by Wall St. Rank held Guardant Health as of Q3 2021.

Based on James Investment Research's 13F filing for Q3 2021, filed 22 Oct 2021.